SEARCH:   Advanced

Blood, Vol. 108, Issue 12, 3898-3905, December 1, 2006 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics Blood Heuser et al. 108: 3898 Supplemental materials for: Heuser et al, Vol 108, Issue 12, 3898-3905 Files in this Data Supplement: Table S1. Response to induction therapy according to MN1 levels (using the optimized MN1 cut point according to maximally selected log-rank statistics) (PDF, 16.7 KB) Figure S1. Overall survival according to MN1 expression levels (using the optimized MN1 cut point according to maximally selected log-rank statistics) (PDF, 22.1 KB) Figure S2. Donor versus no-donor analysis on overall survival according to MN1 expression levels (PDF, 35.1 KB) - (A) Patients with MN1 expression below the median. (B) Patients with MN1 expression above the median. Figure S3. Mean MN1 expression (black bar) and range in different leukemias determined by real-time RT-PCR (PDF, 16.2 KB) - MN1 expression levels were analyzed in peripheral blood mononuclear cells (PB MNCs) of healthy volunteers (n = 6), chronic lymphocytic leukemia cells (CLL; n = 12), chronic myeloid leukemia cells in chronic phase (CML-CP; n = 10) or in blast crisis (CML-BC; n = 2), acute lymphoblastic leukemia cells (ALL; n = 13), and acute myeloid leukemia cells (AML; n = 142). Mean expression values were compared using Student t test. This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020